Phenotypic Transformation of Smooth Muscle in Vasospasm after Aneurysmal Subarachnoid Hemorrhage

Translational Stroke Research

Volumn 5, Issue 3, 2014, Pages 357-364

  Shimamura, Norihito ^a   Ohkuma, Hiroki ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Phenotypic transformation; Smooth muscle cell; Subarachnoid hemorrhage; Vasospasm

Indexed keywords

CILOSTAZOL; CLAZOSENTAN; ENDOTHELIN; FASUDIL; GROWTH FACTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 1BETA; INTERLEUKIN 33; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE SYNTHASE; PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; THROMBIN; THROMBOXANE A2; TRANSIENT RECEPTOR POTENTIAL CHANNEL; TETRAZOLE DERIVATIVE; VASODILATOR AGENT;

ANEURYSM RUPTURE; ARTICLE; BRAIN VASOSPASM; HUMAN; INFLAMMATION; INTRACRANIAL PRESSURE; NONHUMAN; NORADRENALIN RELEASE; PHENOTYPE; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; SUBARACHNOID HEMORRHAGE; ANIMAL; COMPLICATION; METABOLISM; PATHOLOGY; VASCULAR REMODELING; VASCULAR SMOOTH MUSCLE; VASOSPASM, INTRACRANIAL;

ANIMALS; HUMANS; INFLAMMATION; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PHENOTYPE; SUBARACHNOID HEMORRHAGE; TETRAZOLES; VASCULAR REMODELING; VASODILATOR AGENTS; VASOSPASM, INTRACRANIAL;

EID: 84901270174     PISSN: 18684483     EISSN: 1868601X     Source Type: Journal    
DOI: 10.1007/s12975-013-0310-1     Document Type: Article

References (80)

1. King Jr JT. Epidemiology of aneurysmal subarachnoid hemorrhage. Neuroimaging Clin N Am. 1997;7: 659-68.
2. Ohkuma H, Fujita S, Suzuki S. Incidence of aneurysmal subarachnoid hemorrhage in Shimokita, Japan, from 1989 to 1998. Stroke. 2002;33: 195-9.
3. Pluta RM, Hansen-Schwartz J, Dreier J, et al. Cerebral vasospasm following subarachnoid hemorrhage: time for a new world of thought. Neurol Res. 2009;31: 151-8.
4. Morita A, Kirino T, Hashi K, et al. The natural course of unruptured cerebral aneurysms in a Japanese cohort. N Engl J Med. 2012;366: 2474-82.
5. Inagawa T. What are the actual incidence and mortality rates of subarachnoid hemorrhage? Surg Neurol. 1997;47: 47-52.
6. Shimamura N, Munakata A, Ohkuma H. Current management of subarachnoid hemorrhage in advanced age. Acta Neurochir Suppl. 2011;110: 151-5.
7. Broderick JP, Brott TG, Duldner JE, Tomsick T, Leach A. Initial and recurrent bleeding are the major causes of death following subarachnoid hemorrhage. Stroke. 1994;25: 1342-7.
8. Kassell NF, Torner JC, Jane JA, Haley Jr EC, Adams HP. The International Cooperative Study on the Timing of Aneurysm Surgery. Part 2: Surgical results. J Neurosurg. 1990;73: 37-47.
9. Weir B, Macdonald RL, Stoodley M. Etiology of cerebral vasospasm. Acta Neurochir Suppl. 1999;72: 27-46.
10. Findlay JM, Kassell NF, Weir BK, et al. A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm. Neurosurgery. 1995;37: 168-76.
11. Senbokuya N, Kinouchi H, Kanemaru K, et al. Effects of cilostazol on cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a multicenter prospective, randomized, open-label blinded end point trial. J Neurosurg. 2013;118: 121-30.
12. Suzuki S, Sayama T, Nakamura T, et al. Cilostazol improves outcome after subarachnoid hemorrhage: a preliminary report. Cerebrovasc Dis. 2011;32: 89-93.
13. Vajkoczy P, Meyer B, Weidauer S, et al. Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study. J Neurosurg. 2005;103: 9-17.
14. Keyrouz SG, Diringer MN. Clinical review: prevention and therapy of vasospasm in subarachnoid hemorrhage. Crit Care. 2007;11: 220.
15. Munakata A, Ohkuma H, Nakano T, Shimamura N, Asano K, Naraoka M. Effect of a free radical scavenger, edaravone, in the treatment of patients with aneurysmal subarachnoid hemorrhage. Neurosurgery. 2009;64: 423-8.
16. Salomone S, Soydan G, Moskowitz MA, Sims JR. Inhibition of cerebral vasoconstriction by dantrolene and nimodipine. Neurocrit Care. 2009;10: 93-102.
17. Macdonald RL, Kassell NF, Mayer S, et al. Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke. 2008;39: 3015-21.
18. Macdonald RL, Higashida RT, Keller E, et al. Preventing vasospasm improves outcome after aneurysmal subarachnoid hemorrhage: rationale and design of CONSCIOUS-2 and CONSCIOUS-3 trials. Neurocrit Care. 2010;13: 416-24.
19. Brown RJ, Kumar A, Dhar R, Sampson TR, Diringer MN. The relationship between delayed infarcts and angiographic vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery. 2013;72: 702-7.
20. Alexander MR, Owens GK. Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease. Annu Rev Physiol. 2012;74: 13-40.
21. Zhang JH, Badaut J, Tang J, Obenaus A, Hartman R, Pearce WJ. The vascular neural network-a new paradigm in stroke pathophysiology. Nat Rev Neurol. 2012;8: 711-6.
22. Nishimura G, Manabe I, Tsushima K, et al. DeltaEF1 mediates TGF-beta signaling in vascular smooth muscle cell differentiation. Dev Cell. 2006;11: 93-104.
23. Severs NJ, Rothery S, Dupont E, et al. Immunocytochemical analysis of connexin expression in the healthy and diseased cardiovascular system. Microsc Res Tech. 2001;52: 301-22.
24. Geary RL, Williams JK, Golden D, Brown DG, Benjamin ME, Adams MR. Time course of cellular proliferation, intimal hyperplasia, and remodeling following angioplasty in monkeys with established atherosclerosis. A nonhuman primate model of restenosis. Arterioscler Thromb Vasc Biol. 1996;16: 34-43.
25. Wang L, Chen J, Sun Y, et al. Regulation of connexin expression after balloon injury: possible mechanisms for antiproliferative effect of statins. Am J Hypertens. 2005;18: 1146-53.
26. Shroff RC, Shanahan CM. The vascular biology of calcification. Semin Dial. 2007;20: 103-9.
27. Torikoshi K, Abe H, Matsubara T, et al. Protein inhibitor of activated STAT, PIASy regulates alpha-smooth muscle actin expression by interacting with E12 in mesangial cells. PLoS One. 2012;7: e41186.
28. Ferns GA, Reidy MA, Ross R. Balloon catheter de-endothelialization of the nude rat carotid. Response to injury in the absence of functional T lymphocytes. Am J Pathol. 1991;138: 1045-57.
29. Guan H, Gao L, Zhu L, et al. Apigenin attenuates neointima formation via suppression of vascular smooth muscle cell phenotypic transformation. J Cell Biochem. 2012;113: 1198-207.
30. Yeh HI, Lupu F, Dupont E, Severs NJ. Upregulation of connexin43 gap junctions between smooth muscle cells after balloon catheter injury in the rat carotid artery. Arterioscler Thromb Vasc Biol. 1997;17: 3174-84.
31. Jiao L, Wang MC, Yang YA, et al. Norepinephrine reversibly regulates the proliferation and phenotypic transformation of vascular smooth muscle cells. Exp Mol Pathol. 2008;85: 196-200.
32. Macdonald RL, Weir B. Pathology and pathogenesis. In: Macdonald RL, Weir B, editors. Cerebral vasospasm. New York: Academic Press; 2001. p. 87-174.
33. Doczi T, Ambrose J, O'Laoire S. Significance of contrast enhancement in cranial computerized tomography after subarachnoid hemorrhage. J Neurosurg. 1984;60: 335-42.
34. Doczi T, Joo F, Adam G, Bozoky B, Szerdahelyi P. Blood-brain barrier damage during the acute stage of subarachnoid hemorrhage, as exemplified by a new animal model. Neurosurgery. 1986;18: 733-9.
35. Sasaki T, Kassell NF, Yamashita M, Fujiwara S, Zuccarello M. Barrier disruption in the major cerebral arteries following experimental subarachnoid hemorrhage. J Neurosurg. 1985;63: 433-40.
36. Alford PW, Dabiri BE, Goss JA, Hemphill MA, Brigham MD, Parker KK. Blast-induced phenotypic switching in cerebral vasospasm. Proc Natl Acad Sci U S A. 2011;108: 12705-10.
37. Fountas KN, Tasiou A, Kapsalaki EZ, et al. Serum and cerebrospinal fluid C-reactive protein levels as predictors of vasospasm in aneurysmal subarachnoid hemorrhage. Clinical article. Neurosurg Focus. 2009;26: E22.
38. Fassbender K, Hodapp B, Rossol S, et al. Inflammatory cytokines in subarachnoid haemorrhage: association with abnormal blood flow velocities in basal cerebral arteries. J Neurol Neurosurg Psychiatry. 2001;70: 534-7.
39. Chou SH, Feske SK, Simmons SL, et al. Elevated Peripheral Neutrophils and Matrix Metalloproteinase 9 as Biomarkers of Functional Outcome Following Subarachnoid Hemorrhage. Transl Stroke Res. 2011;2: 600-7.
40. Faleiro LC, Machado CR, Gripp Jr A, Resende RA, Rodrigues PA. Cerebral vasospasm: presence of mast cells in human cerebral arteries after aneurysm rupture. J Neurosurg. 1981;54: 733-5.
41. Nam DH, Kim JS, Hong SC, et al. Expression of interleukin-1 beta in lipopolysaccharide stimulated monocytes derived from patients with aneurysmal subarachnoid hemorrhage is correlated with cerebral vasospasm. Neurosci Lett. 2001;312: 41-4.
42. Allen C, Thornton P, Denes A, et al. Neutrophil cerebrovascular transmigration triggers rapid neurotoxicity through release of proteases associated with decondensed DNA. J Immunol. 2012;189: 381-92.
43. Vikman P, Ansar S, Edvinsson L. Transcriptional regulation of inflammatory and extracellular matrix-regulating genes in cerebral arteries following experimental subarachnoid hemorrhage in rats. Laboratory investigation. J Neurosurg. 2007;107: 1015-22.
44. Chaichana KL, Pradilla G, Huang J, Tamargo RJ. Role of inflammation (leukocyte-endothelial cell interactions) in vasospasm after subarachnoid hemorrhage. World Neurosurg. 2010;73: 22-41.
45. Onda H, Kasuya H, Takakura K, et al. Identification of genes differentially expressed in canine vasospastic cerebral arteries after subarachnoid hemorrhage. J Cereb Blood Flow Metab. 1999;19: 1279-88.
46. Miller AM, Liew FY. The IL-33/ST2 pathway-a new therapeutic target in cardiovascular disease. Pharmacol Ther. 2011;131: 179-86.
47. Forsyth EA, Aly HM, Neville RF, Sidawy AN. Proliferation and extracellular matrix production by human infragenicular smooth muscle cells in response to interleukin-1 beta. J Vasc Surg. 1997;26: 1002-7.
48. Murphy AM, Xenocostas A, Pakkiri P, Lee TY. Hemodynamic effects of recombinant human erythropoietin on the central nervous system after subarachnoid hemorrhage: reduction of microcirculatory impairment and functional deficits in a rabbit model. J Neurosurg. 2008;109: 1155-64.
49. Lyons MA, Shukla R, Zhang K, et al. Increase of metabolic activity and disruption of normal contractile protein distribution by bilirubin oxidation products in vascular smooth-muscle cells. J Neurosurg. 2004;100: 505-11.
50. Kasuya H, Weir BK, White DM, Stefansson K. Mechanism of oxyhemoglobin-induced release of endothelin-1 from cultured vascular endothelial cells and smooth-muscle cells. J Neurosurg. 1993;79: 892-8.
51. Ansar S, Larsen C, Maddahi A, Edvinsson L. Subarachnoid hemorrhage induces enhanced expression of thromboxane A2 receptors in rat cerebral arteries. Brain Res. 2010;1316: 163-72.
52. De CF, Janssen PA. 5-Hydroxytryptamine and thromboxane A2 in ischaemic heart disease. Blood Coagul Fibrinolysis. 1990;1: 201-9.
53. Tsurutani H, Ohkuma H, Suzuki S. Effects of thrombin inhibitor on thrombin-related signal transduction and cerebral vasospasm in the rabbit subarachnoid hemorrhage model. Stroke. 2003;34: 1497-500.
54. Hedin U, Daum G, Clowes AW. Heparin inhibits thrombin-induced mitogen-activated protein kinase signaling in arterial smooth muscle cells. J Vasc Surg. 1998;27: 512-20.
55. Mishra-Gorur K, Castellot Jr JJ. Heparin rapidly and selectively regulates protein tyrosine phosphorylation in vascular smooth muscle cells. J Cell Physiol. 1999;178: 205-15.
56. Simard JM, Schreibman D, Aldrich EF, et al. Unfractionated heparin: multitargeted therapy for delayed neurological deficits induced by subarachnoid hemorrhage. Neurocrit Care. 2010;13: 439-49.
57. Conway LW, McDonald LW. Structural changes of the intradural arteries following subarachnoid hemorrhage. J Neurosurg. 1972;37: 715-23.
58. Zhang ZD, Macdonald RL. Contribution of the remodeling response to cerebral vasospasm. Neurol Res. 2006;28: 713-20.
59. Ohkuma H, Tsurutani H, Suzuki S. Changes of beta-actin mRNA expression in canine vasospastic basilar artery after experimental subarachnoid hemorrhage. Neurosci Lett. 2001;311: 9-12.
60. Borel CO, McKee A, Parra A, et al. Possible role for vascular cell proliferation in cerebral vasospasm after subarachnoid hemorrhage. Stroke. 2003;34: 427-33.
61. Hubbell MC, Semotiuk AJ, Thorpe RB, et al. Chronic hypoxia and VEGF differentially modulate abundance and organization of myosin heavy chain isoforms in fetal and adult ovine arteries. Am J Physiol Cell Physiol. 2012;303: C1090-103.
62. Ohkuma H, Suzuki S, Ogane K. Phenotypic modulation of smooth muscle cells and vascular remodeling in intraparenchymal small cerebral arteries after canine experimental subarachnoid hemorrhage. Neurosci Lett. 2003;344: 193-6.
63. Yamaguchi-Okada M, Nishizawa S, Koide M, Nonaka Y. Biomechanical and phenotypic changes in the vasospastic canine basilar artery after subarachnoid hemorrhage. J Appl Physiol. 2005;99: 2045-52.
64. Macdonald RL, Zhang ZD, Takahashi M, et al. Calcium sensitivity of vasospastic basilar artery after experimental subarachnoid hemorrhage. Am J Physiol Heart Circ Physiol. 2006;290: H2329-36.
65. Aihara Y, Jahromi BS, Yassari R, Nikitina E, gbaje-Williams M, Macdonald RL. Molecular profile of vascular ion channels after experimental subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2004;24: 75-83.
66. Weyer GW, Jahromi BS, Aihara Y, et al. Expression and function of inwardly rectifying potassium channels after experimental subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2006;26: 382-91.
67. Takahashi Y, Watanabe H, Murakami M, et al. Involvement of transient receptor potential canonical 1 (TRPC1) in angiotensin II-induced vascular smooth muscle cell hypertrophy. Atherosclerosis. 2007;195: 287-96.
68. Takahashi Y, Watanabe H, Murakami M, et al. Functional role of stromal interaction molecule 1 (STIM1) in vascular smooth muscle cells. Biochem Biophys Res Commun. 2007;361: 934-40.
69. Kumar B, Dreja K, Shah SS, et al. Upregulated TRPC1 channel in vascular injury in vivo and its role in human neointimal hyperplasia. Circ Res. 2006;98: 557-63.
70. Li J, Sukumar P, Milligan CJ, et al. Interactions, functions, and independence of plasma membrane STIM1 and TRPC1 in vascular smooth muscle cells. Circ Res. 2008;103: e97-104.
71. Song JN, Yan WT, An JY, et al. Potential contribution of SOCC to cerebral vasospasm after experimental subarachnoid hemorrhage in rats. Brain Res. 2013;1517: 93-103.
72. Xie A, Aihara Y, Bouryi VA, et al. Novel mechanism of endothelin-1-induced vasospasm after subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2007;27: 1692-701.
73. McGirt MJ, Lynch JR, Parra A, et al. Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage. Stroke. 2002;33: 2950-6.
74. Chou SH, Smith EE, Badjatia N, et al. A randomized, double-blind, placebo-controlled pilot study of simvastatin in aneurysmal subarachnoid hemorrhage. Stroke. 2008;39: 2891-3.
75. Vergouwen MD, de Haan RJ, Vermeulen M, Roos YB. Effect of statin treatment on vasospasm, delayed cerebral ischemia, and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis update. Stroke. 2010;41: e47-52.
76. Shibuya M, Suzuki Y, Sugita K, et al. Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Results of a prospective placebo-controlled double-blind trial. J Neurosurg. 1992;76: 571-7.
77. Furuyama T, Komori K, Shimokawa H, et al. Long-term inhibition of Rho kinase suppresses intimal thickening in autologous vein grafts in rabbits. J Vasc Surg. 2006;43: 1249-56.
78. Naraoka M, Munakata A, Matsuda N, Shimamura N, Ohkuma H. Suppression of the Rho/Rho-Kinase pathway and prevention of cerebral vasospasm by combination treatment with statin and fasudil after subarachnoid hemorrhage in rabbit. Transl Stroke Res. 2013;4: 368-74.
79. Macdonald RL, Higashida RT, Keller E, et al. Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol. 2011;10: 618-25.
80. Kawanabe Y, Takahashi M, Jin X, et al. Cilostazol prevents endothelin-induced smooth muscle constriction and proliferation. PLoS One. 2012;7: e44476.